MiR-145-5p inhibits proliferation and inflammatory responses of RMC through regulating AKT/GSK pathway by targeting CXCL16-Reference-Cited by-同舟云学术

MiR-145-5p inhibits proliferation and inflammatory responses of RMC through regulating AKT/GSK pathway by targeting CXCL16

Author:

Wu Junbiao¹²^ORCID,He Yu³,Luo Yining¹,Zhang Lei⁴,Lin Hua¹,Liu Xusheng⁴,Liu Bihao³,Liang Chunling⁵,Zhou Yuan³,Zhou Jiuyao³

Affiliation:

1. Department of Clinical Pharmacy; The Second Affiliated Hospital; Guangzhou University of Chinese Medicine; Guangzhou Guangdong P.R. China

2. Postdoctoral Scientific Research of Guangzhou University of Chinese Medicine; Guangzhou; Guangdong P.R. China

3. School of Pharmaceutical Sciences; Guangzhou University of Chinese Medicine; Guangzhou Guangdong P.R. China

4. Department of Nephrology; The Second Affiliated Hospital; Guangzhou University of Chinese Medicine; Guangzhou Guangdong P.R. China

5. Section of Immunology & Chinese Medicine; The Second Affiliated Hospital of Guangzhou University of Chinese; Guangzhou Guangdong P.R. China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

China Postdoctoral Science Foundation

TCM Science and Technology of Guangdong Provincial Hospital of Chinese Medicine

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Reference42 articles.

3. Serum microRNAs are altered in various stages of chronic kidney disease: A preliminary study;Brigant;Clinical Kidney Journal,2017

5. Circulating CXCL16 in diabetic kidney disease;Elewa;Kidney & Blood Pressure Research,2016

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献